Flow cytometry detection of CD138 expression continuum between monotypic B and plasma cells is associated with both high IgM peak levels and MYD88 mutation and contributes to diagnosis of Waldenström macroglobulinemia.
IgM
MYD88
Waldenström macroglobulinaemia/lymphoplasmatic lymphoma
flow cytometry
plasma cell
Journal
Cytometry. Part B, Clinical cytometry
ISSN: 1552-4957
Titre abrégé: Cytometry B Clin Cytom
Pays: United States
ID NLM: 101235690
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
revised:
13
01
2021
received:
24
07
2020
accepted:
08
02
2021
pubmed:
27
2
2021
medline:
17
3
2022
entrez:
26
2
2021
Statut:
ppublish
Résumé
Differential diagnosis of Waldenström macroglobulinemia (WM) with other indolent B-cell malignancies is still a challenge. Here, we propose an original and simple analysis of routine flow cytometry (FCM) unraveling the characteristic ongoing plasma cell (PC) differentiation of WM tumor B-cells. FCM analysis of both B-cells and PC was performed on a series of 77 patients with IgM peak. MYD88 and CXCR4 mutations were studied using an allele-specific PCR and by high throughput sequencing. Twenty seven (35%), 46 (58%) and 4 (5%) patients were classified as WM, IgM monoclonal gammopathy of undetermined significance (MGUS) or other B-NHL respectively. MYD88 mutation was found in 25/27 WM (93%) and in 29/46 MGUS (63%). Using FCM, monotypic B-cells were found in 27/27 WM (100%) and 34/46 MGUS (74%). Monotypic CD138pos/CD38pos PCs were detected in 23/27 WM (85%) and 25/46 MGUS (54%). Highlighting the ongoing PC differentiation of WM tumor B-cells by FCM, we evidenced a CD138 expression continuum between monotypic B-cells and PCs. This pattern remained absent in control samples and was significantly associated with higher IgM peaks (p = 6.10 FCM exploration of both B-cells and PC led to identify a CD138 expression continuum as an objective marker of ongoing PC differentiation of WM tumor cells and was strongly associated with increased IgM peak levels and MYD88 mutations. This approach could contribute to place FCM at the forefront of WM diagnosis.
Sections du résumé
BACKGROUND
Differential diagnosis of Waldenström macroglobulinemia (WM) with other indolent B-cell malignancies is still a challenge. Here, we propose an original and simple analysis of routine flow cytometry (FCM) unraveling the characteristic ongoing plasma cell (PC) differentiation of WM tumor B-cells.
METHODS
FCM analysis of both B-cells and PC was performed on a series of 77 patients with IgM peak. MYD88 and CXCR4 mutations were studied using an allele-specific PCR and by high throughput sequencing.
RESULTS
Twenty seven (35%), 46 (58%) and 4 (5%) patients were classified as WM, IgM monoclonal gammopathy of undetermined significance (MGUS) or other B-NHL respectively. MYD88 mutation was found in 25/27 WM (93%) and in 29/46 MGUS (63%). Using FCM, monotypic B-cells were found in 27/27 WM (100%) and 34/46 MGUS (74%). Monotypic CD138pos/CD38pos PCs were detected in 23/27 WM (85%) and 25/46 MGUS (54%). Highlighting the ongoing PC differentiation of WM tumor B-cells by FCM, we evidenced a CD138 expression continuum between monotypic B-cells and PCs. This pattern remained absent in control samples and was significantly associated with higher IgM peaks (p = 6.10
CONCLUSIONS
FCM exploration of both B-cells and PC led to identify a CD138 expression continuum as an objective marker of ongoing PC differentiation of WM tumor cells and was strongly associated with increased IgM peak levels and MYD88 mutations. This approach could contribute to place FCM at the forefront of WM diagnosis.
Identifiants
pubmed: 33634586
doi: 10.1002/cyto.b.21995
doi:
Substances chimiques
Immunoglobulin M
0
MYD88 protein, human
0
Myeloid Differentiation Factor 88
0
SDC1 protein, human
0
Syndecan-1
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
62-69Subventions
Organisme : Comité Orientation Recherche Cancer Limousin
Organisme : Ligue Contre le Cancer
ID : Equipe labellisée Ligue
Informations de copyright
© 2021 International Clinical Cytometry Society.
Références
Baldini, L., Goldaniga, M., Guffanti, A., Broglia, C., Cortelazzo, S., Rossi, A., Morra, E., Colombi, M., Callea, V., Pogliani, E., Ilariucci, F., Luminari, S., Morel, P., Merlini, G., & Gobbi, P. (2005). Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: Proposal for a common prognostic scoring system. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 23, 4662-4668.
Batata, A., & Shen, B. (1993). Diagnostic value of clonality of surface immunoglobulin light and heavy chains in malignant lymphoproliferative disorders. American Journal of Hematology, 43, 265-270.
Cao, X.-X., Meng, Q., Mao, Y.-Y., Su, W., Zhen, J.-F., Shen, K.-N., Zhang, C.-L., Huang, X.-F., Duan, M.-H., Zhang, W., Zhu, T.-N., Cai, H.-C., Chen, M., Zhou, D.-B., & Li, J. (2016). The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients. Leukemia Research, 46, 85-88.
Dwivedi, A. K., Mallawaarachchi, I., & Alvarado, L. A. (2017). Analysis of small sample size studies using nonparametric bootstrap test with pooled resampling method. Statistics in Medicine, 36, 2187-2205.
Frébet, E., Abraham, J., Geneviève, F., Lepelley, P., Daliphard, S., Bardet, V., Amsellem, S., Guy, J., Mullier, F., Durrieu, F., Venon, M.-D., Leleu, X., Jaccard, A., Faucher, J.-L., Béné, M. C., & Feuillard, J. (2011). GEIL Groupe d'Etude Immunologique des Leucémies Study Group. A GEIL flow cytometry consensus proposal for quantification of plasma cells: Application to differential diagnosis between MGUS and myeloma. Cytometry. Part B, Clinical Cytometry, 80, 176-185.
Gachard, N., Parrens, M., Soubeyran, I., Petit, B., Marfak, A., Rizzo, D., Devesa, M., Delage-Corre, M., Coste, V., Laforêt, M. P., de Mascarel, A., Merlio, J. P., Bouabdhalla, K., Milpied, N., Soubeyran, P., Schmitt, A., Bordessoule, D., Cogné, M., & Feuillard, J. (2013). IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas. Leukemia, 27, 183-189.
Hallek, M., Cheson, B. D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Döhner, H., Hillmen, P., Keating, M., Montserrat, E., Chiorazzi, N., Stilgenbauer, S., Rai, K. R., Byrd, J. C., Eichhorst, B., O'Brien, S., Robak, T., Seymour, J. F., & Kipps, T. J. (2018). iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood, 131, 2745-2760.
Langerak, A. W., Groenen, P. J. T. A., Brüggemann, M., Beldjord, K., Bellan, C., Bonello, L., Boone, E., Carter, G. I., Catherwood, M., Davi, F., Delfau-Larue, M.-H., Diss, T., Evans, P. A. S., Gameiro, P., Garcia Sanz, R., Gonzalez, D., Grand, D., Håkansson, Å., Hummel, M., … van Dongen, J. J. M. (2012). EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations. Leukemia, 26, 2159-2171.
Lydersen, S., Fagerland, M. W., & Laake, P. (2009). Recommended tests for association in 2 x 2 tables. Statistics in Medicine, 28, 1159-1175.
Martin, W., Abraham, R., Shanafelt, T., Clark, R. J., Bone, N., Geyer, S. M., Katzmann, J. A., Bradwell, A., Kay, N. E., & Witzig, T. E. (2007). Serum-free light chain-A new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia. Translational Research: The Journal of Laboratory and Clinical Medicine, 149, 231-235.
Moreau, E. J., Matutes, E., A'Hern, R. P., Morilla, A. M., Morilla, R. M., Owusu-Ankomah, K. A., Seon, B. K., & Catovsky, D. (1997). Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). American Journal of Clinical Pathology, 108, 378-382.
Morice, W. G., Chen, D., Kurtin, P. J., Hanson, C. A., & McPhail, E. D. (2009). Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenström's macroglobulinemia. Modern Pathology, 22, 807-816.
Nakayama, S., Yokote, T., Hirata, Y., Iwaki, K., Akioka, T., Miyoshi, T., Takayama, A., Nishiwaki, U., Masuda, Y., Ikemoto, T., Tanaka, H., Nishimura, Y., Tsuji, M., & Hanafusa, T. (2013). An approach for plasma cell myeloma diagnosis by two-color flow cytometry based on kappa/lambda ratios of CD38-gated plasma cells. International Journal of Immunopathology and Pharmacology, 26, 479-483.
Ngo, H. T., Leleu, X., Lee, J., Jia, X., Melhem, M., Runnels, J., Moreau, A.-S., Burwick, N., Azab, A. K., Roccaro, A., Azab, F., Sacco, A., Farag, M., Sackstein, R., & Ghobrial, I. M. (2008). SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia. Blood, 112, 150-158.
Nguyen-Khac, F., Lambert, J., Chapiro, E., Grelier, A., Mould, S., Barin, C., Daudignon, A., Gachard, N., Struski, S., Henry, C., Penther, D., Mossafa, H., Andrieux, J., Eclache, V., Bilhou-Nabera, C., Luquet, I., Terre, C., Baranger, L., Mugneret, F., … Leblondon, V. (2013). Groupe Français d'Etude de la Leucémie Lymphoïde Chronique et Maladie de Waldenström (GFCLL/MW), Groupe Ouest-Est d'étude des Leucémie Aiguës et Autres Maladies du Sang (GOELAMS), Groupe d'Etude des Lymphomes de l'Adulte (GELA). Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia. Haematologica, 98, 649-654.
Owen, R. G., Treon, S. P., Al-Katib, A., Fonseca, R., Greipp, P. R., McMaster, M. L., Morra, E., Pangalis, G. A., San Miguel, J. F., Branagan, A. R., & Dimopoulos, M. A. (2003). Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Seminars in Oncology, 30, 110-115.
Paiva, B., Montes, M. C., García-Sanz, R., Ocio, E. M., Alonso, J., de Las Heras, N., Escalante, F., Cuello, R., de Coca, A. G., Galende, J., Hernández, J., Sierra, M., Martin, A., Pardal, E., Bárez, A., Alonso, J., Suarez, L., González-López, T. J., Perez, J. J., … San Miguel, J. F. (2014). Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's macroglobulinemia: New criteria for differential diagnosis and risk stratification. Leukemia, 28, 166-173.
Pangalis, G. A., Moutsopoulos, H. M., Papadopoulos, N. M., Costello, R., Kokkinou, S., & Fessas, P. (1988). Monoclonal and oligoclonal immunoglobulins in the serum of patients with B-chronic lymphocytic leukemia. Acta Haematologica, 80, 23-27.
Pasricha, S.-R., Juneja, S. K., Westerman, D. A., & Came, N. A. (2011). Bone-marrow plasma cell burden correlates with IgM paraprotein concentration in Waldenstrom macroglobulinaemia. Journal of Clinical Pathology, 64, 520-523.
Petit, B., Parrens, M., Soubeyran, I., Costes-Martineau, V., Gachard, N., Boulin, M., Laurent, C., Marfak, A., Labrousse, F., Bordessoule, D., & Feuillard, J. (2009). Among 157 marginal zone lymphomas, DBA.44(CD76) expression is restricted to tumour cells infiltrating the red pulp of the spleen with a diffuse architectural pattern. Histopathology, 54, 626-631.
Ponzoni, M., Kanellis, G., Pouliou, E., Baliakas, P., Scarfò, L., Ferreri, A. J. M., Doglioni, C., Bikos, V., Dagklis, A., Anagnostopoulos, A., Ghia, P., Stamatopoulos, K., & Papadaki, T. (2012). Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: A reliable substitute for spleen histopathology? The American Journal of Surgical Pathology, 36, 1609-1618.
Preud'homme, J. L., & Seligmann, M. (1972). Immunoglobulins on the surface of lymphoid cells in Waldenström's macroglobulinemia. The Journal of Clinical Investigation, 51, 701-705.
Raimbault, A., Machherndl-Spandl, S., Itzykson, R., Clauser, S., Chapuis, N., Mathis, S., Lauf, J., Alary, A.-S., Burroni, B., Kosmider, O., Fontenay, M., Béné, M. C., Durrieu, F., Bettelheim, P., & Bardet, V. (2019). CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation. British Journal of Haematology, 184, 625-633.
Rizzo, D., Chauzeix, J., Trimoreau, F., Woillard, J. B., Genevieve, F., Bouvier, A., Labrousse, J., Poli, C., Guerin, E., Dmytruk, N., Remenieras, L., Feuillard, J., & Gachard, N. (2015). IgM peak independently predicts treatment-free survival in chronic lymphocytic leukemia and correlates with accumulation of adverse oncogenetic events. Leukemia, 29, 337-345.
Schlenker, E. (2016). Tips and tricks for successful application of statistical methods to biological data. Methods in Molecular Biology, 1366, 271-285.
Starr, A. G., Caimi, P. F., Fu, P., Massoud, M. R., Meyerson, H., Hsi, E. D., Mansur, D. B., Cherian, S., Cooper, B. W., De Lima, M. J. G., Lazarus, H. M., Gerson, S. L., Jagadeesh, D., Smith, M. R., Dean, R. M., Pohlman, B. L., Hill, B. T., & William, B. M. (2016). Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era. British Journal of Haematology, 175, 275-280.
Starr, A. G., Caimi, P. F., Fu, P., Massoud, M. R., Meyerson, H., Hsi, E. D., Mansur, D. B., Cherian, S., Singh, A. D., Cooper, B. W., De Lima, M. J. G., Lazarus, H. M., Gerson, S. L., Jagadeesh, D., Smith, M. R., Dean, R. M., Pohlman, B. L., Hill, B. T., & William, B. M. (2016). Dual institution experience of extranodal marginal zone lymphoma reveals excellent long-term outcomes. British Journal of Haematology, 173, 404-412.
Terstappen, L. W., Johnsen, S., Segers-Nolten, I. M., & Loken, M. R. (1990). Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry. Blood, 76, 1739-1747.
Treon, S. P., Xu, L., Yang, G., Zhou, Y., Liu, X., Cao, Y., Sheehy, P., Manning, R. J., Patterson, C. J., Tripsas, C., Arcaini, L., Pinkus, G. S., Rodig, S. J., Sohani, A. R., Harris, N. L., Laramie, J. M., Skifter, D. A., Lincoln, S. E., & Hunter, Z. R. (2012). MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. The New England Journal of Medicine, 367, 826-833.
van Dongen, J. J. M., Langerak, A. W., Brüggemann, M., Evans, P. A. S., Hummel, M., Lavender, F. L., Delabesse, E., Davi, F., Schuuring, E., García-Sanz, R., van Krieken, J. H. J. M., Droese, J., González, D., Bastard, C., White, H. E., Spaargaren, M., González, M., Parreira, A., Smith, J. L., … Macintyre, E. A. (2003). Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia, 17, 2257-2317.
Wang, W., & Lin, P. (2020). Lymphoplasmacytic lymphoma and Waldenström macroglobulinaemia: Clinicopathological features and differential diagnosis. Pathology (Philadelphia, Pa.), 52, 6-14.
Xu, L., Hunter, Z. R., Yang, G., Zhou, Y., Cao, Y., Liu, X., Morra, E., Trojani, A., Greco, A., Arcaini, L., Varettoni, M., Brown, J. R., Tai, Y.-T., Anderson, K. C., Munshi, N. C., Patterson, C. J., Manning, R. J., Tripsas, C. K., Lindeman, N. I., & Treon, S. P. (2013). MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Blood, 121, 2051-2058.